TOPICS

Day: September 1, 2020

Lidose-Isotretinoin Administered Without Food Improves Quality of Life in Patients With Severe Recalcitrant Nodular Acne: An Open-Label, Single-Arm, Phase IV Study

J Clin Aesthet Dermatol. 2020;13(9):15–20 by Andrea L. Zaenglein, MD; Jeanett Segal, MD; Charles Darby, MSc; and James Q. Del Rosso, DO Dr. Zaenglein is with Departments of Dermatology and Pediatrics at Penn State College of Medicine, Hershey Medical Center in Hershey, Pennsylvania. Dr. Segal is with Sun Pharmaceutical Industries, Inc., in Princeton, New Jersey.

CONTINUE READING »

Oral Antibiotic Treatment Options for Acne Vulgaris

J Clin Aesthet Dermatol. 2020;13(9):26–32 by Hilary Baldwin, MD Dr. Baldwin is the Medical Director of the Acne Treatment and Research Center in Brooklyn, New York and is with Rutgers Robert Wood Johnson Medical Center in New Brunswick, New Jersey. ABSTRACT: Acne vulgaris is the most common dermatological disease in the United States, affecting up

CONTINUE READING »

Linear Depigmentation After an Intralesional Corticosteroid Injection

J Clin Aesthet Dermatol. 2020;13(9):49–51 by Gabriella Vasile, DO; Mojgan Hosseinipour, DO; Cindy Hoffman, DO; and Charles Gropper, MD Dr. Vasile is a Dermatology resident at Larkin Community Hospital of Palm Springs Dermatology in Hialeah, Florida. Dr. Hosseinipour is a Dermatology resident at St. Barnabas Hospital in Bronx, New York. Dr. Gropper is a Dermatologist

CONTINUE READING »